About the ESTRO
Founded in 1980, ESTRO exists to advance all aspects of radiation oncology through a range of activities for its members and the wider healthcare and patient communities.
ESTRO promotes excellence through education, professional development, promotion of research and dissemination of outcomes, courses and conferences. ESTRO is focused on improving all aspects of patient care and supports the role of radiation oncology in the multimodality treatment of cancer.
ESTRO’s principal objectives are to:
- Support and promote all aspects of radiation oncology
- Develop standards for quality assurance in radiation oncology, radiation physics, radiation technology and radiobiology throughout Europe and encourage their implementation
- Improve the standard of cancer treatment by establishing radiation oncology as a clinical specialty integrated with other cancer treatment modalities
- Promote the international exchange of scientific information on radiotherapy and oncology and related scientific fields including radiation physics, radiobiology and radiation technology
- Set standards for education and practice in radiation oncology and provide educational courses and materials to meet the needs of all radiation oncology professionals
- Establish relationships and encourage co-operation with international, national and regional societies and organisations in the field of radiation oncology
ESTRO Conferences
ESTRO has established an international reputation for organising events covering all aspects of radiation oncology and the multidisciplinary treatment of cancer. From major conferences with several thousand delegates to meetings for smaller, highly specialised groups, ESTRO can be relied upon to provide an excellent scientific programme with all the support expected from experienced conference organisers to ensure that meetings provide the opportunity for the vital exchange of knowledge and experience and the opportunity for networking focused on research initiatives and developments leading to excellence in patient care.
Please find below the list of the ESTRO conferences and congresses the society is organising for 2009.
2009 ESTRO meetings:
- PREVENT, Prediction, Recognition, Evaluation and Eradication of Normal Tissue effects of Radiotherapy, Brussels, 11-12 January
- ICHNO, International Meeting on Innovative Approaches in Head and Neck Oncology, Barcelona, 26-28 February
- GEC/ESTRO Brachytherapy Meeting, Porto, 13-16 May
- 11th International Wolfsberg Meeting on Molecular Radiation Biology/Oncology (in association with ESTRO), Wolfsberg, 27-29 June
- 10th Biennial ESTRO Meeting on Physics and Radiation Technology for Clinical Radiotherapy, Maastricht, 30 August-3 September
- ECCO15, The European Cancer Conference (ESTRO 28), Berlin, 20-24 September
Find out more on ESTRO events and on Radiotherapy and Oncology on www.estro-events.org
Education
Since its first teaching course in 1985, ESTRO has become an internationally recognised provider of high quality education to meet the need for basic training and continuing professional development in radiotherapy and oncology.
ESRO, ESTRO School of Radiotherapy and Oncology, promotes multidisciplinary education in oncology, with the objective of standardising knowledge and clinical practice, whilst recognising the diversity of radiation oncology practice in different parts of the world.
Click here to find out the calendar of the 2009 ESTRO teaching courses.
Find out more on ESRO on www.estro-education.org
ESTRO membership
Since its foundation, ESTRO has grown to become an international organisation with 5000 members now spanning five continents and all the specialist disciplines involved in the multimodality treatment of cancer. The increasing membership endorses the importance of European and international cooperation to support and advance education, research and networking across all areas of radiation oncology.
Find out more on ESTRO membership on www.estro-members.org
ESTRO board and committees
The Board consists of Steering Committee members and Councillors:
Steering Committee 2008
President | V. Grégoire (Brussels, Belgium) |
Past-president | M. Baumann (Dresden, Germany) |
President-elect | J. Bourhis (Paris, France) |
Treasurer | H. Stankusova (Praha, Czech Republic) |
Secretary | C. Grau (Aarhus, Denmark) |
Executive administrator | U. Ricardi (Torino, Italy) |
Editor in Chief | J. Overgaard (Aarhus, Denmark) |
Board Members 2008:
J. Yarnold (Sutton, United Kingdom)
M. Verheij (Amsterdam, The Netherlands)
T. Knöös (Lund, Sweden)
S. Magrini (Brescia, Italy)
C. Carrie (Lyon, France)
I. Monteiro Grillo (Lisboa, Portugal)
B. McClean (Dublin, Ireland)
P. Strojan (Lubjiana, Slovenia)
H.P. Rodemann (Tübingen, Germany)
N. Willich (Münster, Germany)
Chairpersons Committees 2008
Radiobiologists | H.P. Rodemann (Tübingen, Germany) |
GEC/ESTRO | G. Kovacs (Lübeck, Germany) |
EBR | J.W.H. Leer (Nijmegen, The Netherlands) |
Education | R. Pötter (Vienna, Austria) |
RTT | A. Osztavics (Vienna, Austria) |
Physicists | D.R. Olsen (Oslo, Norway) |
Clinical Committee | D. Hollywood (Dublin, Ireland) |
European Institute | V. Khoo (London, UK) |
B. Mijnheer (Amsterdam, The Netherlands) |






